Integral Molecular at ACT 2026
Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website
Integral Molecular takes part in 2 sessions at ACT 2026 in San Antonio, and exhibits at Booth 706. Its program centres on checking antibody specificity without animals, comparing a membrane protein array and tissue cross-reactivity studies against clinical safety findings. It also covers the qualification path for this kind of new approach method as an ISTAND drug development tool.
| Organization | ACT 2026 Attendance |
|---|---|
Integral Molecular Philadelphia, PA | |
Antibody discovery and protein engineering company; its Membrane Proteome Array screens antibody specificity and is being qualified as a non-animal safety tool. | Booth Exhibiting at Booth 706 Mon, Nov 169:30am–6:30pmTue, Nov 178:00am–4:30pm Poster Mon Nov 16 5:00pm–6:30pm Talk Tue Nov 17 3:45pm–4:15pm |
Instantly find 20 buyers from Integral Molecular
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction